GleamWall
中文EN

RMTI ROCKWELL MEDICAL, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1041024 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.0%
TTM net income YoY-2.5%
TTM EPS YoY95.2%
Revenue 3-yr CAGR-3.5%
Net income 3-yr CAGR—

Margins

Gross margin18.1%
Operating margin-7.1%
Net margin-7.8%
FCF margin1.1%
EBITDA margin-4.6%

Returns

ROE-16.1%
ROA-9.9%
ROIC (approx.)-12.8%
Asset turnover1.27x

Leverage & solvency

Liabilities / assets42.0%
Debt / equity0.27x
Current ratio2.47x
Interest coverage-4.56x

Cash quality & payout

Operating cash flow / net income-0.47x
Accruals ratio-14.5%
Payout ratio—
Capex / revenue2.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$69.26M$101.49M
Cost of revenue$57.56M$84.00M
Gross profit$11.70M$17.48M
R&D expense$0$19,000
SG&A expense$14.03M$14.11M
Operating income-$4.69M$608,000
Interest expense$1.12M$1.25M
Pretax income-$5.31M-$480,000
Income tax$0$0
Net income-$5.31M-$480,000
EBITDA-$2.50M$2.79M
EPS (basic)-0.15-0.03
EPS (diluted)-0.15-0.03
Weighted avg. shares (diluted)35.97M31.06M
Balance sheet
Cash & equivalents$10.71M$15.66M
Short-term investments$14.29M$5.94M
Receivables$8.14M$8.29M
Inventory$3.42M$5.78M
Current assets$38.16M$37.03M
PP&E, net$4.63M$5.79M
Goodwill$921,000$921,000
Intangibles$9.66M$10.21M
Total assets$57.15M$59.21M
Current liabilities$9.58M$14.09M
Short-term debt$0—
Long-term debt$8.83M$8.47M
Total debt$8.83M$8.47M
Total liabilities$20.16M$26.62M
Shareholders' equity$36.98M$32.59M
Net debt-$1.89M-$7.19M
Shares outstanding3.94M34.06M
Cash flow statement
Operating cash flow-$659,000$4.20M
Capital expenditure$542,000$1.01M
Free cash flow-$1.20M$3.19M
Investing cash flow-$8.54M-$4.87M
Financing cash flow$4.25M$7.35M
Depreciation & amortization$2.19M$2.18M
Stock-based compensation$1.82M$1.29M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.